|
AF (n=92) |
Control (n=68) |
p value |
FBG (mg/dl) |
128.5 ± 10 |
126.6 ± 7 |
0.182 |
HbA1C (%) |
7.5 (5.9–8.8) |
7.2 (5.2–8.7) |
0.073 |
T.Cholesterol (mg/dl) |
211±15 |
207 ± 12 |
0.072 |
Creatinine (mg/dl) |
0.77 ± 0.17 |
0.75 ± 0.14 |
0.430 |
Hb (g/dL) |
14.3 ± 0.9 |
14.1 ± 0.8 |
0.147 |
Hct (%) |
43.3± 4.1 |
42.7± 4.3 |
0.372 |
RDW (%) |
13.6 (11.5–15.2) |
12.8 (11.2–14.6) |
0.0001* |
MCV (fL) |
86.9 ± 5.3 |
85.4 ± 4.6 |
0.063 |
WBC (103/µL) |
8.13 ± 2.19 |
7.75 ± 2.3 |
0.290 |
NLR |
2.20 (0.8–3.9) |
2.17 (0.5–4.2) |
0.062 |
Platelets count (103/µL) |
253.4 ± 31.8 |
247.4 ± 36.3 |
0.302 |
MPV (fL) |
8.31 ± 1.12 |
7.99 ± 1.39 |
0.109 |
hsCRP (mg/L) |
1.88 ± 0.22 |
0.45 ± 0.13 |
<0.0001* |
IL-33 (pg/ml) |
155.2 (118.2–172.5) |
92.6 (76.4–121.8) |
<0.0001* |
ST2 (pg/ml) |
970.5 ± 98.6 |
361.4 ± 44.8 |
<0.0001* |
|
FBG means fasting blood glucose; Hb hemoglobin; Hct hematocrit; MCV corpuscular volume; WBC white blood cell count; MPV mean platelet volume; NLR neutrophil/lymphocyte ratio; RDW red cell distribution width; WBC white blood cell count. * Significant |
Table 2: Laboratory results of the studied groups. |